###begin article-title 0
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
Ovarian steroids regulate tachykinin and tachykinin receptor gene expression in the mouse uterus
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
In the mouse uterus, pregnancy is accompanied by changes in tachykinin and tachykinin receptor gene expression and in the uterotonic effects of endogenous tachykinins. In this study we have investigated whether changes in tachykinin expression and responses are a result of changes in ovarian steroid levels.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
We quantified the mRNAs of tachykinins and tachykinin receptors in uteri from ovariectomized mice and studied their regulation in response to estrogen and progesterone using real-time quantitative RT-PCR. Early (3 h) and late (24 h) responses to estrogen were evaluated and the participation of the estrogen receptors (ER), ERalpha and ERbeta, was analyzed by treating mice with propylpyrazole triol, a selective ERalpha agonist, or diarylpropionitrile, a selective agonist of ERbeta.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 147 151 <span type="species:ncbi:10090">mice</span>
All genes encoding tachykinins (Tac1, Tac2 and Tac4) and tachykinin receptors (Tacr1, Tacr2 and Tacr3) were expressed in uteri from ovariectomized mice. Estrogen increased Tac1 and Tacr1 mRNA after 3 h and decreased Tac1 and Tac4 expression after 24 h. Tac2 and Tacr3 mRNA levels were decreased by estrogen at both 3 and 24 h. Most effects of estrogen were also observed in animals treated with propylpyrazole triol. Progesterone treatment increased the levels of Tac2.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
###xml 312 317 <span type="species:ncbi:10090">mouse</span>
These results show that the expression of tachykinins and their receptors in the mouse uterus is tightly and differentially regulated by ovarian steroids. Estrogen effects are mainly mediated by ERalpha supporting an essential role for this estrogen receptor in the regulation of the tachykinergic system in the mouse uterus.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 62 63 62 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 114 115 114 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 210 212 210 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 276 277 276 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 342 343 342 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 349 351 349 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 370 371 370 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 564 565 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 566 567 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 622 624 608 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 629 631 615 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 686 687 672 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 688 689 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 900 901 886 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 902 903 888 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
Uterine function is tightly controlled by ovarian steroids [1-5]. The physiological responses to acute estrogen (E2) occur in two temporally distinct steps. Early responses appear within the first 2-3 h after E2 administration while late responses are observed 16-24 h after E2, with each step involving activation of distinct sets of genes [4,5]. E2 and progesterone (P4) exert their effects by binding to specific transcription factor receptors, the estrogen receptors alpha (ERalpha) and beta (ERbeta) and the progesterone receptors (PR A and B), respectively [2-7]. In addition to these classical genotropic effects, E2 and P4 activate extranuclear, non-genomic signaling cascades [8,9]. It is still unclear whether non-genomic effects are mediated by membrane receptors distinct from the nuclear receptors, or additionally involve activation of classical ERs or PRs located outside the nucleus [4-9].
###end p 11
###begin p 12
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 349 354 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2 </italic>
###xml 411 416 411 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac4 </italic>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 642 644 642 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 656 657 656 657 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 667 669 667 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 681 682 681 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 695 697 695 697 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 709 710 709 710 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 748 753 748 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr1</italic>
###xml 783 789 783 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr2 </italic>
###xml 822 828 822 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr3 </italic>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 993 994 993 994 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1044 1045 1044 1045 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1064 1065 1064 1065 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1078 1080 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
Accumulating evidence suggests that tachykinins (TKs) play a role in the regulation of uterine function [3,10]. TKs comprise a family of peptides, which in mammals includes substance P (SP), neurokinin A (NKA) neurokinin B (NKB) and hemokinin-1 (HK) [11-17]. In mice, SP and NKA are encoded by the Tac1 gene (accession number NM_009311), NKB by the Tac2 gene (accession number ENSMUST00000026466) and HK by the Tac4 gene (accession number NM_053093) [10-14]. Their biological effects are mediated by receptors belonging to the family of G protein-coupled receptors. Three different tachykinin receptors are currently recognized, namely the NK1 receptor (NK1R), the NK2 receptor (NK2R) and the NK3 receptor (NK3R) which, in mice, are encoded by the Tacr1(accession number NM_009313), Tacr2 (accession number NM_009314) and Tacr3 (accession number NM_021382) genes, respectively [10-17]. The endogenous tachykinins bind with differing affinities to each of the tachykinin receptors. Thus, the NK1R is activated preferentially by SP and HK, the NK2R by NKA and the NK3R by NKB [16,17].
###end p 12
###begin p 13
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 506 507 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 554 555 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
Tachykinins modulate reproductive function at both central and peripheral levels [18-35]. In the central nervous system, SP, NKA and NKB are expressed in subpopulations of hypothalamic and pituitary neurons where they influence, and are influenced by, gonadotropin and gonadal steroid levels [18-22] and modulate the synthesis and/or secretion of oxytocin [28]. In the reproductive tract, these peptides are expressed in sensory nerves and in non-neuronal cells within the placenta, the ovary, the uterus [3,10,24-26,29-34], the testes and the prostate [3,36]. They are also present in other reproductive cells including corpora lutea, oocytes and spermatozoa [33,35,37].
###end p 13
###begin p 14
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 381 382 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 414 416 414 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 422 424 422 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 552 553 552 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 563 564 563 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 269 274 <span type="species:ncbi:9606">women</span>
###xml 279 283 <span type="species:ncbi:10116">rats</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 781 786 <span type="species:ncbi:10090">mouse</span>
We have previously found that all genes encoding TKs and their receptors are expressed in the mammalian uteri and that their expression and function vary during the ovarian cycle, throughout pregnancy and with age, [3,10,29,30,38,39]. In late pregnant and non-pregnant women, in rats, and in late pregnant mice, TKs induce myometrial contractions that are mediated mainly by the NK2R with minor participation of NK1 and NK3 receptors [10,29,30,39]. In contrast, in non-pregnant mice, the predominant receptor mediating myometrial contractions is the NK1R, with NK2R playing a minor role [10,29,39]. The reasons for this difference between species remain unclear. Indeed, little is known about the physiological mechanisms that regulate the expression of TKs and their receptors in mouse uterus and in particular the influence of ovarian steroids upon their expression.
###end p 14
###begin p 15
###xml 76 78 76 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 83 85 83 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 106 137 106 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1, Tac2, Tac4, Tacr1, Tacr2 </italic>
###xml 141 147 141 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr3 </italic>
###xml 322 323 314 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 324 326 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 421 422 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 623 625 602 604 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 645 646 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 658 659 637 638 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 729 730 708 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 731 732 710 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 762 763 741 742 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
In this study, we have analyzed the direct effects of the ovarian steroids E2 and P4 on the expression of Tac1, Tac2, Tac4, Tacr1, Tacr2 and Tacr3 in uteri from ovariectomized mice. In addition, we have investigated the effects of the selective agonist of the estrogen receptor alpha (ERalpha) propylpyrazole triol (PPT) [7,40], and the selective agonist of the estrogen receptor beta (ERbeta) diarylpropionitrile (DPN) [7], in order to define the roles played by ERalpha and ERbeta in the regulation of TK and TK receptor gene expression. We have also analyzed the effects of estren, a selective activator of non-genomic E2 signaling pathways [8]. Because E2-induced changes in gene expression occur as early or late responses [4,5], animals were treated with E2, PPT, DPN or estren for either 3 or 24 h.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
Animals and treatments
###end title 17
###begin p 18
###xml 327 337 321 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ad libitum</italic>
###xml 519 521 513 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1014 1016 993 995 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 1148 1150 1127 1129 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1204 1206 1182 1184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 1330 1332 1308 1310 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1533 1534 1510 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1535 1536 1512 1513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1537 1538 1514 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1539 1541 1516 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 562 567 <span type="species:ncbi:10090">mouse</span>
###xml 661 666 <span type="species:ncbi:10090">mouse</span>
###xml 743 748 <span type="species:ncbi:10090">mouse</span>
###xml 794 799 <span type="species:ncbi:10090">mouse</span>
###xml 881 885 <span type="species:ncbi:10090">mice</span>
###xml 987 991 <span type="species:ncbi:10090">mice</span>
###xml 1029 1034 <span type="species:ncbi:10090">mouse</span>
###xml 1157 1162 <span type="species:ncbi:10090">mouse</span>
###xml 1212 1217 <span type="species:ncbi:10090">mouse</span>
###xml 1339 1344 <span type="species:ncbi:10090">mouse</span>
Ethical approval for this study was obtained from Consejo Superior de Investigaciones Cientificas (Spain). Virgin female Swiss mice (7-9 weeks, 20-25 g) were purchased from Charles River Laboratories (Barcelona, Spain), housed at 22degreesC under controlled lighting (12:12-h light/dark cycle) and provided with food and water ad libitum. Animals were bilaterally ovariectomized under avertin anesthesia (250 mg/Kg, i.p.). Fifteen days later, they were left untreated (control, untreated mice) or treated s.c. with a) E2 (17beta-estradiol benzoate, Sigma, 1 mug/mouse); b) the selective ERalpha agonist propylpyrazole triol (PPT, Tocris, Ellisville, MO, 75 mug/mouse); c) the selective ERbeta agonist diarylpropionitrile (DPN, Tocris, 100 mug/mouse); d) estren (Steraloids Newport, RI, 300 mug/mouse) or e) the same volume of vehicle (olive oil, 100 mul) (control, vehicle-treated mice). In all cases, uteri were collected 3 and 24 h after the injection. In a second set of experiments, mice were treated with a) P4 (Sigma, 2 mg/mouse per day for 2 days) or its vehicle, and uteri collected 24 h after the last injection; b) a single injection of E2 (1 mug/mouse) or its vehicle, followed 24 h later by P4 (2 mg/mouse per day for 2 days) or its vehicle and uteri collected 24 h after the last injection; c) a single injection of E2 (1 mug/mouse) or its vehicle and uteri collected 72 h after treatment. The pharmacological doses of steroid receptor ligands used in the present experiments were based on previously published studies [2,4-8,39].
###end p 18
###begin title 19
Real-time RT-PCR
###end title 19
###begin p 20
###xml 193 195 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 288 289 282 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 377 379 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 542 547 530 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 657 659 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 696 701 684 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 899 900 887 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 944 949 932 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 966 967 954 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1019 1023 1004 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Actb</italic>
###xml 1080 1086 1065 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ppp1cb</italic>
###xml 1131 1136 1116 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh</italic>
###xml 1192 1198 1177 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Polr2a</italic>
###xml 1332 1334 1317 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1335 1337 1320 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1338 1340 1323 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
###xml 1310 1315 <span type="species:ncbi:10090">mouse</span>
###xml 1320 1323 <span type="species:ncbi:10116">rat</span>
Uterine samples were rapidly immersed in RNAlater (Ambion, Huntingdon, UK) and stored at -80degreesC until use. Total RNA isolation and cDNA synthesis were carried out as previously described [29]. The cDNA samples were amplified by PCR using specific oligonucleotide primer pairs (Table 1) designed with the software Primer 3 and purchased from Sigma-Genosys (Cambridge, UK) [29]. A specific probe (ndegrees 88, Home probe Library, Exiqon, Vedbaek, Denmark), chosen with the program Probefinder assay design (Exiqon), was used to detect the Tac1 transcript (88 bp) since this gene was present in faint amounts in uteri from pregnant and non-pregnant mice [29]. With this approach, we found that Tac1 mRNA levels were 4.5- and 3.0-fold higher in untreated ovariectomized mice, than in estrus and diestrus virgin mice, respectively (unpublished observations). The specific primer pair shown in Table 1 was employed in subsequent experiments for Tac1 detection. Table 1 also shows the primers used to amplify beta-actin (Actb), protein phosphatase 1 catalytic subunit beta-isoform (Ppp1cb), glyceraldehyde-3-phosphate-dehydrogenase (Gapdh) and polymerase (RNA) II (DNA directed) polypeptide A (Polr2a), which were chosen as housekeeping genes for normalizing the PCR data on the basis of previous studies in the mouse and rat uterus [29,36,37].
###end p 20
###begin p 21
Nucleotide sequence of the specific primers used in PCR amplifications.
###end p 21
###begin p 22
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Actb </italic>
###xml 175 180 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh</italic>
###xml 182 199 179 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ppp1cb and Polr2a</italic>
Shown are the structures of forward (F) and reverse (R) primers of indicated target genes and the size expected for each PCR-amplified product. Primers for Actb (beta-actin), Gapdh, Ppp1cb and Polr2a, used as housekeeping genes, are also shown.
###end p 22
###begin p 23
###xml 413 415 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
Real-time quantitative PCR was performed on a Bio-Rad iCycler iQ real-time detection apparatus (Bio-Rad Laboratories, Hercules, CA) using a FastStart SYBR Green Master (Roche Diagnostics GmbH, Manheim, Germany). The parameters of PCR amplification were: 10 sec at 94degreesC, 20 sec at 60degreesC and 30 seconds at 72degreesC, for 45 cycles. The identity of each product was established by DNA sequence analysis [29] and the specificity of PCR reactions was confirmed by melting curve analysis of the products and by size verification of the amplicon in a conventional agarose gel.
###end p 23
###begin p 24
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 296 298 296 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T </sub>
###xml 364 366 360 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T </sub>
###xml 370 371 366 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 386 387 382 383 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 423 425 411 413 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T </sub>
###xml 434 436 418 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T </sub>
###xml 456 458 436 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T </sub>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
Real-time PCR data were expressed as the fold change of the target gene expression relative to the geometric mean (g.m.) mRNA expression of the housekeeping genes in each sample, as described by Vandesompele et al. [41]. The fold change in gene expression was calculated by the formula: , where CT is the threshold cycle, calculated by the iCycler software, DeltaCT = (CTtarget gene - CTg.m.reference genes) and DeltaDeltaCT = (DeltaCT test sample - DeltaCT control sample). A pool of uterine cDNAs from untreated, ovariectomized mice, was used as a control sample throughout the study and the ratio of the target gene mRNA/geometric mean of the four reference genes mRNA in this control sample was designated as 1. Each assay was performed in triplicate and negative controls were run for every assay.
###end p 24
###begin title 25
Data analysis
###end title 25
###begin p 26
###xml 48 50 46 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 207 209 205 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 255 269 253 267 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GRAPHPAD PRISM</underline>
###xml 316 318 314 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
All values are expressed as the mean +/- S.E.M; n represents the number of mice used. Statistical procedures included one-way ANOVA followed by Dunnett's test for multiple comparisons and Student's unpaired t test to compare the means of two groups using GRAPHPAD PRISM 4. Statistical significance was accepted when P < 0.05.
###end p 26
###begin title 27
Results
###end title 27
###begin p 28
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1</italic>
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2</italic>
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac4</italic>
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr1</italic>
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr2 </italic>
###xml 55 61 55 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr3 </italic>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
The transcripts for Tac1, Tac2, Tac4, Tacr1, Tacr2 and Tacr3 were detected in uteri from ovariectomized mice. In all experiments and with all target genes, mRNA expression values were similar in untreated and vehicle-treated mice (Fig. 1, Fig. 2, Fig. 3 and Fig. 4).
###end p 28
###begin p 29
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1</italic>
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2 </italic>
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac4 </italic>
###xml 119 120 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 184 0 184 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Real-time quantitative PCR analysis of A) <italic>Tac1</italic>; B) <italic>Tac2 </italic>and C) <italic>Tac4 </italic>expression in uterine cDNA from mice treated with E<sub>2</sub>, propylpyrazole triol (PPT), diarylpropionitrile (DPN)or estren</bold>
###xml 283 285 283 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 652 654 648 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 768 775 764 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#9830;</sup>
###xml 775 777 765 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 292 297 <span type="species:ncbi:10090">mouse</span>
###xml 311 316 <span type="species:ncbi:10090">mouse</span>
###xml 331 336 <span type="species:ncbi:10090">mouse</span>
###xml 354 359 <span type="species:ncbi:10090">mouse</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
Real-time quantitative PCR analysis of A) Tac1; B) Tac2 and C) Tac4 expression in uterine cDNA from mice treated with E2, propylpyrazole triol (PPT), diarylpropionitrile (DPN)or estren. Uteri were collected from ovariectomized mice untreated (control) or treated for 3 or 24 h with E2 (1 mug/mouse) PPT (75 mug/mouse) DPN (100 mug/mouse) estren (300 mug/mouse) or the corresponding vehicle. Values are expressed as the fold change of each target-gene expression, relative to the geometric mean mRNA expression of 4 housekeeping genes. Each bar represents the mean of uterine cDNA samples from 5-10 different mice, with S.E.M. shown by vertical lines. *P < 0.05, significant difference versus mRNA levels in uteri from ovariectomized mice treated for 3 h with vehicle; diamondP < 0.05, significant difference versus mRNA levels in uteri from ovariectomized mice treated for 24 h with vehicle; one-way ANOVA.
###end p 29
###begin p 30
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1</italic>
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2 </italic>
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac4 </italic>
###xml 119 121 119 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 126 127 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 0 152 0 152 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Real-time quantitative PCR analysis of A) <italic>Tac1</italic>; B) <italic>Tac2 </italic>and C) <italic>Tac4 </italic>expression in uterine cDNA from mice treated with E<sub>2 </sub>and P<sub>4</sub>, alone or in combination</bold>
###xml 237 239 237 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 276 278 275 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 331 333 330 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 336 338 335 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 629 630 628 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 630 632 629 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 641 643 640 642 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 648 650 647 649 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 668 670 667 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 676 677 675 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 677 679 676 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 688 690 687 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 695 697 694 696 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 715 717 714 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 723 724 722 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 724 726 723 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 735 737 734 736 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 740 741 739 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 744 746 743 745 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 749 751 748 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 764 766 763 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 777 779 776 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 784 786 783 785 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 797 799 796 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 246 251 <span type="species:ncbi:10090">mouse</span>
###xml 284 289 <span type="species:ncbi:10090">mouse</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
Real-time quantitative PCR analysis of A) Tac1; B) Tac2 and C) Tac4 expression in uterine cDNA from mice treated with E2 and P4, alone or in combination. Uteri were collected from ovariectomized mice untreated (control) or treated with E2 (1 mug/mouse, 72 h) or its vehicle, P4 (2 mg/mouse per day for 2 days) or its vehicle, and E2 + P4 or the corresponding vehicles. Values are expressed as the fold change of each target-gene expression, relative to the geometric mean mRNA expression of 4 housekeeping genes. Each bar represents the mean of uterine cDNA samples from 5-10 different mice, with S.E.M. shown by vertical lines. aP < 0.05, E2 vs. E2 vehicle, unpaired t test; bP < 0.05, P4 vs. P4 vehicle, unpaired t test; cP < 0.05, E2 + P4, E2 + P4 vehicle and E2 vehicle + P4 vs. E2 vehicle + P4 vehicle, one-way ANOVA.
###end p 30
###begin p 31
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr1</italic>
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr2 </italic>
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr3 </italic>
###xml 111 112 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 176 0 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Real-time quantitative PCR analysis of A) <italic>Tacr1</italic>; B) <italic>Tacr2 </italic>and C) <italic>Tacr3 </italic>in uterine cDNA from mice treated with E<sub>2</sub>, propylpyrazole triol (PPT), diarylpropionitrile (DPN)or estren</bold>
###xml 275 277 275 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 649 651 645 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 765 772 761 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#9830;</sup>
###xml 772 774 762 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 284 289 <span type="species:ncbi:10090">mouse</span>
###xml 303 308 <span type="species:ncbi:10090">mouse</span>
###xml 323 328 <span type="species:ncbi:10090">mouse</span>
###xml 346 351 <span type="species:ncbi:10090">mouse</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 853 857 <span type="species:ncbi:10090">mice</span>
Real-time quantitative PCR analysis of A) Tacr1; B) Tacr2 and C) Tacr3 in uterine cDNA from mice treated with E2, propylpyrazole triol (PPT), diarylpropionitrile (DPN)or estren. Uteri were collected from ovariectomized mice untreated (control) or treated for 3 or 24 h with E2 (1 mug/mouse) PPT (75 mug/mouse) DPN (100 mug/mouse) estren (300 mug/mouse) or the corresponding vehicle. Values are expressed as the fold change of each target-gene expression relative to the geometric mean mRNA expression of 4 housekeeping genes. Each bar represents the mean of uterine cDNA samples from at least five different mice, with SEM shown by vertical lines. *P < 0.05, significant difference versus mRNA levels in uteri from ovariectomized mice treated for 3 h with vehicle; diamondP < 0.05, significant difference versus mRNA levels in uteri from ovariectomized mice treated for 24 h with vehicle; one-way ANOVA.
###end p 31
###begin p 32
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr1</italic>
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr2 </italic>
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr3 </italic>
###xml 122 124 122 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 0 155 0 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Real-time quantitative PCR analysis of A) <italic>Tacr1</italic>; B) <italic>Tacr2 </italic>and C) <italic>Tacr3 </italic>expression in uterine cDNA from mice treated with E<sub>2 </sub>and P<sub>4</sub>, alone or in combination</bold>
###xml 240 242 240 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 279 281 278 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 334 336 333 335 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 339 341 338 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 632 633 631 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 633 635 632 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 644 646 643 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 651 653 650 652 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 671 673 670 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 679 680 678 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 680 682 679 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 691 693 690 692 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 696 697 695 696 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 700 702 699 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 705 707 704 706 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 720 722 719 721 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 733 735 732 734 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 740 742 739 741 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 753 755 752 754 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 249 254 <span type="species:ncbi:10090">mouse</span>
###xml 287 292 <span type="species:ncbi:10090">mouse</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
Real-time quantitative PCR analysis of A) Tacr1; B) Tacr2 and C) Tacr3 expression in uterine cDNA from mice treated with E2 and P4, alone or in combination. Uteri were collected from ovariectomized mice untreated (control) or treated with E2 (1 mug/mouse, 72 h) or its vehicle, P4 (2 mg/mouse per day for 2 days) or its vehicle, and E2 + P4 or the corresponding vehicles. Values are expressed as the fold change of each target-gene expression, relative to the geometric mean mRNA expression of 4 housekeeping genes. Each bar represents the mean of uterine cDNA samples from 5-10 different mice, with S.E.M. shown by vertical lines. aP < 0.05, E2 vs. E2 vehicle, unpaired t test; cP < 0.05, E2 + P4, E2 + P4 vehicle and E2 vehicle + P4 vs. E2 vehicle + P4 vehicle, one-way ANOVA.
###end p 32
###begin title 33
Effects on tachykinin gene expression
###end title 33
###begin p 34
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 77 79 77 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 179 184 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 247 249 247 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 533 535 533 535 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 547 549 547 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 595 596 595 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 617 622 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
Tac1 expression was increased 3-fold in uterine cDNA from mice treated with E2 for 3 h, compared with vehicle-treated (3 h) mice (Fig. 1A). PPT, DPN and estren also increased the Tac1 transcript 3 h after their administration (Fig. 1A). At 24 h, E2 decreased 7-fold the expression of Tac1 compared to the respective vehicle controls (Fig. 1A). Treatment with PPT for 24 h caused a 5-fold decrease in Tac1 mRNA while DNP and estren had no significant effects (Fig 1A). Tac1 mRNA levels remained low in mice after 72 h treatment with E2 (Fig. 2A). P4 was without effect and did not influence the E2-induced decrease in Tac1 expression (Fig. 2A).
###end p 34
###begin p 35
###xml 16 18 16 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2 </italic>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2 </italic>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 315 320 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2 </italic>
###xml 368 370 368 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 412 413 412 413 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 468 470 468 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 475 477 475 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
Treatment with E2 for 3 or 24 h caused large decreases in Tac2 expression, compared with vehicle-treated mice (Fig. 1B). The decrease was still significant at 72 h (P < 0.05, see Fig. 2B). PPT decreased Tac2 mRNA after 3 and 24 h treatment, while neither DPN nor estren had significant effects (P > 0.05, Fig. 2B). Tac2 mRNA was increased 3-fold in mice treated with P4 (Fig. 2B); neither this increase nor the E2-induced decrease were seen in mice treated with both E2 and P4 (Fig. 2B).
###end p 35
###begin p 36
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac4 </italic>
###xml 61 63 61 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac4 </italic>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
Tac4 mRNA levels were decreased 3-fold in mice treated with E2 for 24 h, compared with uteri from corresponding vehicle-treated mice. As shown in Figs. 1C and 2C, none of the other treatments modified Tac4 expression.
###end p 36
###begin title 37
Effects on tachykinin receptor gene expression
###end title 37
###begin p 38
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr1 </italic>
###xml 61 63 61 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 103 105 103 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 265 266 265 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 298 299 298 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 323 329 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr1 </italic>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
Tacr1 expression was increased in mice treated for 3 h with E2 or PPT (Fig. 3A). After treatment with E2 or PPT for 24 h, the mRNA levels were similar to those observed in control, vehicle-treated mice. DPN and estren had no effects either at 3 or 24 h (Fig. 3A). P4, alone or in combination with E2, was without effect on Tacr1 levels (Fig. 4A).
###end p 38
###begin p 39
###xml 57 59 57 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 64 66 64 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 154 160 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr2 </italic>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Compared with uteri from control, vehicle-treated mice, E2 and P4 (alone or in combination), PPT, DPN and estren did not cause significant alterations in Tacr2 mRNA levels (P > 0.05, Figs. 3B and 4B).
###end p 39
###begin p 40
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr3 </italic>
###xml 53 55 53 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 194 200 194 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr3 </italic>
###xml 258 260 258 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 281 283 281 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 298 304 298 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr3 </italic>
###xml 342 343 342 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 382 388 382 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr3 </italic>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
Tacr3 expression was decreased in mice treated with E2 for 3 or 24 h and in mice treated with PPT for 24 h, compared with vehicle-treated mice (Fig. 3C). DPN and estren had no effect (Fig. 3C). Tacr3 mRNA levels remained low in uteri from mice treated with E2 for 72 h (Fig. 4C). P4 did not modify Tacr3 expression and did not influence the E2-induced decrease in the expression of Tacr3 (Fig. 4C).
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 351 353 351 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 358 360 358 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
The present study has shown that ovarian steroids tightly and differentially regulate the expression of tachykinin and tachykinin receptor genes in the mouse uteri. Since the uterus is often considered a model to investigate the effects of steroid hormones on gene transcription, this study represents the first analysis of the regulatory effects of E2 and P4 on the whole tachykinin family.
###end p 42
###begin p 43
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 478 480 478 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 591 596 591 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 724 726 724 726 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 782 787 782 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 834 839 834 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 879 880 879 880 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 883 885 883 885 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 902 907 902 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 944 945 944 945 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
Tac1 mRNA and the tachykinin peptides encoded by this gene, predominantly SP and NKA, are widely expressed in neuronal and non-neuronal cells at both central and peripheral levels [3,10,20-22,26,29,32]. Several workers have investigated the effects of ovarian steroids on the expression of this gene and its protein products in the CNS, particularly in the hypothalamic-pituitary axis [18,20-22,32], often with conflicting results. Our findings show that Tac1 was regulated by E2 in a complex and time-dependent manner, with both stimulatory and inhibitory effects. The higher expression of Tac1 in ovariectomized animals, compared to non-ovariectomized mice [29], together with the observation that 24-72 h treatment with E2 causes a strong and long-lasting down-regulation of the Tac1 transcript clearly points to the importance of Tac1 regulation by estrogen. In contrast to E2, P4 had no effect on Tac1 expression nor did it influence the E2-induced decrease.
###end p 43
###begin p 44
###xml 100 101 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 102 103 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 125 127 118 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 223 224 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 225 227 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 285 286 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 338 340 321 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 351 352 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 453 455 432 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 471 476 450 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
In the mouse uterus there is a predominance of ERalpha, while ERbeta modulates some of its effects [4-6]. In our study, the E2 effect was mimicked by PPT, a highly selective agonist of ERalpha devoid of activity on ERbeta [7,40]. In contrast DPN, a highly selective agonist of ERbeta [7], or estren, a purported activator of non-genomic E2 signaling [8], were without effect. It thus seems likely that nuclear ERalpha mediates the inhibitory effect of E2 (after 24 h) on Tac1 expression.
###end p 44
###begin p 45
###xml 60 62 60 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 141 143 141 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 202 204 202 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 425 427 425 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Early physiological responses of the mouse uterus to acute E2 appear within the first 2-3 h while late responses are observed 16-24 h after E2 [4,5]. Consistent with these findings, 3 h treatment with E2 caused an increase in Tac1 mRNA levels. This early response was also observed in animals treated with PPT, DPN or estren. These findings suggest that early stimulation of Tac1 is mediated by both genomic and non-genomic E2 pathways.
###end p 45
###begin p 46
###xml 6 7 6 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 165 167 165 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac1 </italic>
###xml 219 225 219 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr1 </italic>
###xml 232 238 232 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr1 </italic>
###xml 447 448 443 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 520 522 516 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
The NK1R is the preferred receptor for SP, while NKA can also act as a potent agonist on NK1R [13-17]. Therefore, it was interesting to observe that treatment with E2 for 3 h caused a parallel increase in both Tac1 and Tacr1 mRNAs. Tacr1 gene expression was also increased in mice treated for 3 h with PPT revealing the participation of ERalpha. Since tachykinins are potent inflammatory mediators, the present findings may suggest that SP(NKA)-NK1R ligand-receptor pair could play a role in mediating rapid effects of E2 in the uterus, such as hyperemia, water imbibition and attraction of immune cells.
###end p 46
###begin p 47
###xml 39 40 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 55 57 55 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 76 77 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr1 </italic>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 302 303 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
Treatment of ovariectomized mice with E2, PPT, DPN or P4 did not decrease NK1R gene expression. This finding was unexpected, as we previously found that the transcript for Tacr1 decreases by about 11-fold on day 17 of pregnancy, compared with its expression in uteri from non-pregnant mice [29]. The NK1R is regulated by many different mechanisms and it may be that near term, in addition to ovarian steroids, other hormonal, humoral, placental or neural influences may influence its expression.
###end p 47
###begin p 48
###xml 6 7 6 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 189 190 189 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 301 307 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr2 </italic>
###xml 385 387 385 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 391 392 391 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 455 461 455 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr2 </italic>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 679 685 679 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr2 </italic>
###xml 806 807 806 807 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 195 200 <span type="species:ncbi:10090">mouse</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 661 666 <span type="species:ncbi:10090">mouse</span>
The NK2R is the key tachykinin receptor mediating contractile responses to TKs in the near term uteri from all mammalian species studied [10,29,30]. Furthermore, the participation of the NK2R in mouse myometrial contractions is higher under conditions of estrogen dominance [29,39]. The expression of Tacr2 in uteri from ovariectomized mice was, however, unaffected by treatment with E2 or P4. This result is consistent with our previous observation that Tacr2 mRNA levels are similar in uteri from pregnant or non-pregnant mice and remain essentially constant during different hormonal stages [29]. Taken together, these findings suggest that, at least in the mouse uterus, the Tacr2 gene is not a direct target for ovarian steroids. The increased response in late pregnancy to agonists that act at the NK2R [29] may therefore reflect regulation at a posttranscriptional level.
###end p 48
###begin p 49
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 443 467 443 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ornithorhynchus anatinus</italic>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 434 442 <span type="species:ncbi:9258">platypus</span>
###xml 443 467 <span type="species:ncbi:9258">Ornithorhynchus anatinus</span>
NKB, together with SP, kisspeptin and dinorphin, is present in a group of hypothalamic neurons that also express estrogen and progesterone receptors [19,21,42,43]. NKB is also expressed at all main levels in the female genital tract [10,24-26,29-33] and its excessive secretion from the placenta may cause, in part, some of the symptoms of pre-eclampsia [24,25,31]. Recently, the genome sequence of a non-placental mammal, namely the platypus Ornithorhynchus anatinus, has become available [44] and by phylogenetic analysis, we found that the NKB encoding gene is present (Ensemble entry ENSOANG00000022075). This finding clearly shows that NKB plays additional roles in reproduction, apart from its participation in placental pathophysiology.
###end p 49
###begin p 50
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 196 198 196 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 209 210 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 279 284 279 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2 </italic>
###xml 365 367 365 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 131 134 <span type="species:ncbi:10116">rat</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
NKB is elevated in the human female hypothalamus after menopause [21]. Additionally, its expression in the rodent brain and in the rat uterus is increased by age and ovariectomy and decreased by E2 treatment [3,19,38,42]. These findings and our current observations showing that Tac2 mRNA is strongly repressed in uteri from young ovariectomized mice treated with E2 at all times of treatment indicate that at both central and peripheral levels, NKB over-expression is secondary to ovarian failure [19,38].
###end p 50
###begin p 51
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2 </italic>
###xml 203 205 199 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 228 233 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2 </italic>
###xml 318 320 314 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 431 433 427 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 434 435 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 532 537 528 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2 </italic>
###xml 611 613 607 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 651 653 647 649 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 780 782 776 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 783 784 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 805 807 801 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 840 845 836 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2 </italic>
###xml 1019 1024 1015 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2 </italic>
###xml 1152 1154 1148 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
###xml 1049 1054 <span type="species:ncbi:10090">mouse</span>
Tac2 inhibition was mediated by ERalpha because it was observed in mice treated for 3 or 24 h with PPT, but not with DPN or estren. In addition, our data show, to our knowledge for the first time, that P4 treatment up-regulated Tac2 gene expression in uteri from ovariectomized mice. The mechanism that mediates this P4 effect remains unclear, as in ovariectomized mice, the expression of PRs fall as a consequence of the lack of E2 [7]. Although the presence of a basal population of nuclear PRs cannot be excluded, the effects on Tac2 expression may more probably be mediated by activation of membrane-bound P4 receptors distinct from PRs. Several P4 membrane receptor candidates are present in uteri from ovariectomized mice and the expression of some of them is increased by P4 [9]. Up-regulation by P4 would permit a local increase in Tac2 expression following ovulation or in the case of copulation and successful fertilization. These data are in agreement with our previous observations showing that the highest Tac2 levels were found in the mouse uterus around the time of implantation and that these were strongly decreased at late pregnancy [29].
###end p 51
###begin p 52
###xml 38 39 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 153 155 153 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr3 </italic>
###xml 229 230 229 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 365 367 365 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 431 433 427 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 483 488 479 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac2 </italic>
###xml 492 498 488 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tacr3 </italic>
###xml 562 564 558 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 574 575 570 571 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 601 603 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 707 708 703 704 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 748 750 744 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 755 757 751 753 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4 </sub>
###xml 778 780 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 781 783 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 929 934 925 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAC3 </italic>
###xml 938 943 934 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TACR3</italic>
###xml 945 947 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1010 1011 1006 1007 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 917 922 <span type="species:ncbi:9606">human</span>
At the peripheral level the role of NK3R, like that of its preferred ligand NKB, remains poorly understood [10,31,32,36,45]. The present data show that E2 strongly reduces Tacr3 expression in uteri from ovariectomized mice. The E2-induced responses were mimicked by PPT but not by DPN or estren, providing the first evidence, to our knowledge, that the effects of E2 on this receptor are mediated by ERalpha. The observation that E2 caused a rapid and concomitant down-regulation of Tac2 and Tacr3 expression supports the existence of an important link between E2 and the NK3R/NKB activation pathway [38]. Moreover, the tight regulation of both genes strongly argues for a role of NKB, acting through the NK3R, in mediating some of the effects of E2 and P4 on uterine function [34,38]. In this context, a recent report has established a correlation between familial hypogonadotropic hypogonadism and mutations in the human genes TAC3 and TACR3.[23] providing clear evidence for the importance of NKB and the NK3R in reproduction.
###end p 52
###begin p 53
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac4 </italic>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 212 213 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 489 494 489 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac4 </italic>
###xml 520 522 520 522 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 539 544 539 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tac4 </italic>
###xml 577 579 577 579 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
The Tac4 gene is expressed in the placenta, the ovary, the uterus, and also in oocytes and blastocyst-stage embryos [12,29,32,37]. In the mouse uteri, HK caused myometrial contractions that are mediated by the NK1R and are decreased at late pregnancy [39]. Apart from its effects on myometrial contractility, the physiological role of HK at the reproductive level remains poorly understood and its direct regulation by ovarian steroids has not been studied. The present data show that the Tac4 gene is also a target of E2 and suggest that Tac4 expression is down-regulated by E2 surges, as those observed in mammals before ovulation or near labor.
###end p 53
###begin title 54
Conclusion
###end title 54
###begin p 55
###xml 133 134 133 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
This study suggests that uterine tachykinins and tachykinin receptors are important targets of ovarian steroids and particularly of E2, acting at ERalpha. The whole tachykinergic system appears involved in the regulation of reproductive functions.
###end p 55
###begin title 56
Abbreviations
###end title 56
###begin p 57
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 97 99 97 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 111 112 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 117 119 117 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 131 132 131 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 137 139 137 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 150 151 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 283 284 269 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
SP: substance P; NKA: neurokinin A; NKB: neurokinin B; HK1: hemokinin 1; TK: tachykinin; NK1R: NK1 receptor; NK2R: NK2 receptor; NK3R: NK3 receptor; E2: estrogen; ERalpha: estrogen receptor alpha; ERbeta: estrogen receptor beta; PPT: propylpyrazole triol; DPN: diarylpropionitrile; P4: progesterone; PR: progesterone receptor; CNS: central nervous system.
###end p 57
###begin title 58
Competing interests
###end title 58
###begin p 59
The authors declare that they have no competing interests.
###end p 59
###begin title 60
Authors' contributions
###end title 60
###begin p 61
FMP carried out PCR experiments and helped to write the manuscript. COP performed ovariectomy, ovarian steroid treatments and collected uterine samples. EP performed the statistical analysis. JNP and LC wrote the manuscript. FMP and LC designed the study. All authors read and approved the final manuscript.
###end p 61
###begin title 62
Acknowledgements
###end title 62
###begin p 63
This work was supported by grants from Ministerio de Educacion y Ciencia (BFU2005-04495-C02-01/BFI and CTQ2007-61024/BQU) and Junta de Andalucia (FQM261), Spain.
###end p 63
###begin article-title 64
Sex hormones and excitation-contraction coupling in the uterus: the effects of oestrous and hormones
###end article-title 64
###begin article-title 65
Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation
###end article-title 65
###begin article-title 66
Tachykinins and tachykinin receptors: effects in the genitourinary tract
###end article-title 66
###begin article-title 67
Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen
###end article-title 67
###begin article-title 68
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
Estren behaves as a weak estrogen rather than a nongenomic selective activator in the mouse uterus
###end article-title 68
###begin article-title 69
Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus
###end article-title 69
###begin article-title 70
###xml 179 183 <span type="species:ncbi:10116">rats</span>
The integrated action of estrogen receptor isoforms and sites with progesterone receptor in the gonadotrope modulates LH secretion: evidence from tamoxifen-treated ovariectomized rats
###end article-title 70
###begin article-title 71
Classical genotropic versus kinase-initiated regulation of gene transcription by the estrogen receptor alpha
###end article-title 71
###begin article-title 72
###xml 144 149 <span type="species:ncbi:10090">mouse</span>
###xml 154 159 <span type="species:ncbi:9606">human</span>
Expression of progesterone receptor membrane component 1 and its partner serpine 1 mRNA binding protein in uterine and placental tissues of the mouse and human
###end article-title 72
###begin article-title 73
Mammalian tachykinins and uterine smooth muscle: the challenge escalates
###end article-title 73
###begin article-title 74
Overview of the primary structure, tissue-distribution, and functions of tachykinins and their receptors
###end article-title 74
###begin article-title 75
Hemokinins and endokinins
###end article-title 75
###begin article-title 76
Tachykinins in the immune system
###end article-title 76
###begin article-title 77
Tachykinins and tachykinin receptors: structure and activity relationships
###end article-title 77
###begin article-title 78
Molecular aspects of the tachykinin receptors
###end article-title 78
###begin article-title 79
Concepts in characterization of tachykinin receptors
###end article-title 79
###begin article-title 80
Peripheral actions of tachykinins
###end article-title 80
###begin article-title 81
Modulation of the hypothalamo-pituitary-gonadal axis and the pineal gland by neurokinin A, neuropeptide K and neuropeptide gamma
###end article-title 81
###begin article-title 82
###xml 18 23 <span type="species:ncbi:9606">human</span>
Menopause and the human hypothalamus: Evidence for the role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback
###end article-title 82
###begin article-title 83
###xml 98 101 <span type="species:ncbi:10116">rat</span>
Gonadal steroid regulation of substance P (SP) and SP-encoding messenger ribonucleic acids in the rat anterior pituitary and hypothalamus
###end article-title 83
###begin article-title 84
###xml 158 163 <span type="species:ncbi:9606">women</span>
Hypertrophy and increased gene expression of neurons containing neurokinin-B and substance-P messenger ribonucleic acids in the hypothalami of postmenopausal women
###end article-title 84
###begin article-title 85
###xml 152 155 <span type="species:ncbi:10116">rat</span>
Ovarian steroid modulation of neurokinin contents in hypothalamus, pituitary, trigeminal nucleus, and cervical spinal cord of the ovariectomized female rat
###end article-title 85
###begin article-title 86
TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction
###end article-title 86
###begin article-title 87
Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia
###end article-title 87
###begin article-title 88
Has the mechanism by which the endocrine placenta scavenges the mother whilst sparing the foetus been unmasked?
###end article-title 88
###begin article-title 89
Tachykinins and ovarian function in mammals
###end article-title 89
###begin article-title 90
###xml 181 184 <span type="species:ncbi:10116">rat</span>
The in vitro effect of substance P on the GnRH-induced LH release depends on the steroidal environment and is reverted by a NK1 receptor antagonist (RP 67580) in the cycling female rat
###end article-title 90
###begin article-title 91
###xml 26 29 <span type="species:ncbi:10116">rat</span>
Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists
###end article-title 91
###begin article-title 92
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Functional and molecular characterization of tachykinins and tachykinin receptors in the mouse uterus
###end article-title 92
###begin article-title 93
###xml 40 45 <span type="species:ncbi:9606">human</span>
Tachykinins and tachykinin receptors in human uterus
###end article-title 93
###begin article-title 94
Gene regulation of neurokinin B and its receptor NK3 in late pregnancy and pre-eclampsia
###end article-title 94
###begin article-title 95
Tachykinin family genes and their receptors are differentially expressed in the hypothyroid ovary and pituitary
###end article-title 95
###begin article-title 96
###xml 60 66 <span type="species:ncbi:9913">bovine</span>
Coexpression of preprotachykinin A and B transcripts in the bovine corpus luteum and evidence for functional neurokinin receptor activity in luteal endothelial cells and ovarian macrophages
###end article-title 96
###begin article-title 97
###xml 69 72 <span type="species:ncbi:10116">rat</span>
Tachykinin receptor and neutral endopeptidase gene expression in the rat uterus: characterization and regulation in response to ovarian steroid treatment
###end article-title 97
###begin article-title 98
###xml 44 49 <span type="species:ncbi:9606">human</span>
A role for tachykinins in the regulation of human sperm motility
###end article-title 98
###begin article-title 99
###xml 69 74 <span type="species:ncbi:9606">human</span>
mRNA expression of tachykinins and tachykinin receptors in different human tissues
###end article-title 99
###begin article-title 100
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
###xml 43 46 <span type="species:ncbi:10116">rat</span>
A role for tachykinins in female mouse and rat reproductive function
###end article-title 100
###begin article-title 101
###xml 109 112 <span type="species:ncbi:10116">rat</span>
Increase in neurokinin B expression and in tachykinin NK(3) receptor-mediated response and expression in the rat uterus with age
###end article-title 101
###begin article-title 102
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Functional characterisation of hemokinin-1 in mouse uterus
###end article-title 102
###begin article-title 103
Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists
###end article-title 103
###begin article-title 104
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
###end article-title 104
###begin article-title 105
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Estrogen regulation of neurokinin B gene expression in the mouse arcuate nucleus is mediated by estrogen receptor alpha
###end article-title 105
###begin article-title 106
###xml 124 127 <span type="species:ncbi:10116">rat</span>
Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 peptide
###end article-title 106
###begin article-title 107
###xml 23 31 <span type="species:ncbi:9258">platypus</span>
Genome analysis of the platypus reveals unique signatures of evolution
###end article-title 107
###begin article-title 108
Opinion: NK3 receptor antagonists: the next generation of antipsychotics?
###end article-title 108

